Searchable abstracts of presentations at key conferences in endocrinology

ea0014p570 | (1) | ECE2007

The role of vasopressin in the hypothalamo-pituitary-adrenal axis regulation during the perinatal period: paradoxical corticosterone elevation without an ACTH rise

Zelena Dóra , Barna István , Mergl Zsuzsa , Domokos Ágnes , Csabai Katalin , Makara Gábor B

Early life events have special importance in the development and may affect the lifetime vulnerability to diseases. For correct interpretation of the long-term consequences it is crucial to understand the immediate effects. The role of vasopressin in hypothalamo-pituitary-adrenal axis regulation as well as in stress-related affective disorders is important therefore we addressed the question if the lack of this hormone will modify the perinatal stress reactivity.<p class="...

ea0012s10 | Novel regulation of orphan receptor function | SFE2006

Repression of NR5A nuclear receptors by SUMO and DEAD-box proteins

Wang Y , Sampathkumar Y , Peiris DN , Manan RA , Lebedeva LA , Suzawa M , Wadekar SA , Desclozeaux M , Ingraham HA , Lee MB

The Nuclear Receptor Subfamily 5A member, Steroidogenic Factor 1 (SF-1, Ad4BP, NR5A1), is critical for steroidogenesis, stress responses, sexual differentiation and body weight regulation in mice. Patients with rare mutations in SF-1 have confirmed its role in male sexual differentiation and adrenal response to physiological stress in humans. In contrast, Liver Receptor Homologue 1 (LRH-1, FTF, CPF, NR5A2) is involved in endoderm development, bile acid and lipid metabolism and...

ea0056p735 | Endocrine tumours and neoplasia | ECE2018

Utility of a 3D spheroid cell culture system in neuroendocrine tumors

Herrera-Martinez AD , van Dungen ESR , Dogan F , van Koetsveld1 PM , Castano JP , Feelders RA , Hofland LJ

In vitro 3D cell culture systems seem to appropriately reproduce the tumor cell microenvironment, including nutrients-oxygen conditions and cell-cell interactions. These models may better mimic in vivo tumor conditions and more accurately reproduce drug treatments effects. Since most in vitro studies in neuroendocrine tumors (NETs) are performed in 2D culture systems (monolayer), we aimed to compare the monolayer system with a 3D spheroid cell cultur...

ea0092ps2-16-06 | Thyroid Cancer clinical 2 | ETA2023

Prevalence, screening and clinical implications of thyroid cancer in patients with acromegaly: A cohort study

Hanife Oğuz Seda , Fırlatan Buşra , Nahit Sendur Suleyman , Unluturk Uğur , Dagdelen Selcuk , Erbas Tomris

Objective: Thyroid cancer (TC) screening in acromegaly is a controversial topic. The Endocrine Society opposes routine TC screening in acromegaly patients without a palpable nodule, and the American Thyroid Association does not consider acromegaly to be a high-risk condition for developing TC. However, acromegaly is associated with an increased risk of TC, and some centers opt for thyroid ultrasound screening even in the absence of palpable thyroid nodules. Being one of the su...

ea0099p598 | Late-Breaking | ECE2024

Changing landscape of comorbidities in acromegaly: a single-center experience

Ercan Polat , Fırlatan Buşra , Nahit Sendur Suleyman , Hanife Oguz Seda , Dagdelen Selcuk , Erbas Tomris

Purpose: Acromegalic patients carry a high burden of cardiovascular, metabolic, and neoplastic diseases, but there are limited studies focusing on morphological and functional changes in the kidneys.Methods: The data of acromegalic patients followed over a 43-year period at our center were examined for the development of chronic kidney disease (CKD), renal cysts, and urological cancers.Results: A total of 394 patients (202M/192F, m...

ea0081p359 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

New insights into obesity treatment provided by smart technologies and telemedicine

Jakubikova Iva , Štolbova Kristyna , Novodvorsky Peter , Dvořakova Iveta , Doležalova Barbora , Kalina Szabolcs , Raška Petr , Kautzner Josef , Haluzik Martin

Introduction: Obesity represents a major public health challenge and is linked with increased risk of multiple medical conditions including atrial fibrillation (AF). We have recently published the study protocol of the ‘The Effect of complex weigHt-reducing interventiOns on rhythm control in oBese subjects wITh Atrial Fibrillation’ (HOBIT-AF) trial. Here we communicate the preliminary results with the focus on the use of smart technologies and telemedicine.<...

ea0081ep669 | Pituitary and Neuroendocrinology | ECE2022

Predictors of surgical outcome and early criteria of remission in acromegaly

Astafyeva Ludmila , Shkarubo Alexsey , Sameh R.A. Ibrahim , Badmaeva Inna , Sidneva Yuliya , Strunina Julia , Kutin Maxim , Fomicev Dmitrii , Sharipov Oleg , Andreev Dmitrii , Chernov Ilya , Kalinin Pavel

Objective: To analyze the remission factors of surgical treatment of acromegaly Methods: A retrospective study involving 227 patients with acromegaly: 143 (63%) women and 84 (37%) men were operated via trassphenoidal endoscopic approach for pituitary adenoma removal between the periods of 2018-2021. The average age was 45 years [36.00, 56.00]. 118 patients had 6 months follow-up period (3-40 months). The IGF-1 index used for the evaluation, which was cal...

ea0067o18 | Oral Presentations | EYES2019

Transcriptome profiling explains clinical characteristics of PRKACA mutant cortisol-producing adenomas

Kim Jung Hee , Jang Insoon , Kim Su-Jin , Song Ra-Young , Kim Kwang Soo , Lee Hyun-Seob , Seong Moon Woo , Shin Chan Soo , Lee Kyu Eun

Objectives: The activating mutation (L206R) in PRKACA has been reported in more than 30–50% of cases with cortisol-producing adenomas (CPAs). We aimed to compare the clinical characteristics and gene expression profiling between PRKACA L206R mutant and wild type CPAs.Methods: We included 57 subjects with CPAs who underwent adrenalectomy at Seoul National University Hospital. Sanger sequencing for PRKACA w...

ea0049ep802 | Nuclear receptors and Signal transduction | ECE2017

5α-THB as a novel anti-inflammatory drug: The roles of the glucocorticoid and mineralocorticoid receptors

Abernethie Amber , Gastaldello A , Morgan RA , Mitchell C , McInnes KJ , Beck K , Odermatt A , Houtman R , Melchars D , Meijer OC , Hadoke PWF , Livingstone DEW , Walker BR , Andrew R

Glucocorticoids (GC) are potent anti-inflammatory compounds, acting mainly through the glucocorticoid receptor (GR). GC therapy, however, has debilitating side-effects, necessitating safer new alternative therapies. The natural GC metabolite 5α-Tetrahydrocorticosterone (5αTHB) is anti-inflammatory in vivo in mice, but with fewer side-effects. Its mechanism of action is unknown, and here we test signalling via GR and the mineralocorticoid receptor (MR). 5&#94...

ea0037ep596 | Obesity and cardiovascular endocrinology | ECE2015

Increased expression of ATP-binding cassette transporter A1 by cilostazol may be a possible mechanism for its protective effect against hepatic steatosis

Cha Bong-Soo , Park Tae Sun , Jeon Byung Hun , Lee Yong-Ho , Yun Mi Ra , Lee Byung Wan , Kang Eun Seok , Lee Hyun Chul

Objective: Cilostazol, a selective inhibitor of phosphodiesterase 3, which has been widely used in patients with atherosclerotic diseases, is known to have additional beneficial effects on dyslipidemia. ATP-binding cassette transporter A1 (ABCA1) plays a critical role in the regulation of intracellular cholesterol levels in hepatocytes. We aimed to investigate the effect of Cilostazol on hepatic steatosis and its underlying mechanism related to ABCA1.Met...